×

RNA-Guided Human Genome Engineering

  • US 20140342457A1
  • Filed: 06/30/2014
  • Published: 11/20/2014
  • Est. Priority Date: 12/17/2012
  • Status: Active Grant
First Claim
Patent Images

1. A method of modulating expression of a target nucleic acid in a cell comprisingproviding to the cell a guide RNA complementary to the target nucleic acid sequence,providing to the cell a Cas9 protein having inactive nuclease domains that interacts with the guide RNA and binds to the target nucleic acid sequence in a site specific manner,wherein the Cas 9 protein having inactive nuclease domains includes a transcriptional activator or repressor domain as a fusion protein for modulating target nucleic acid expression in vivo,wherein the guide RNA and the Cas9 protein including the transcriptional activator or repressor domain co-localize to the target nucleic acid sequence and wherein the transcriptional activator or repressor domain modulates expression of the target nucleic acid.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×